IP Library Assignment 041117/0023
Patent Assignment
Reel/Frame 041117/0023

Change of Name

Recorded: 2016-12-21 Pages: 6
Assignor
AERIS THERAPEUTICS, INC.
Executed: 2011-04-12
Assignee
AERIS THERAPEUTICS, LLC
10K GILL STREET, WOBURN, MASSACHUSETTS, 01801
Covered Property (1)
Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers
Patent: 9,561,301 →
Application: 14/686,306 →
Publication: US 2015/0217020
Related Assignments (11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 21, 2016
From: INGENITO, EDWARD P.; KROM, JAMES A.; SCHWARZ, ALEXANDER; TSAI, LARRY W.
To: AERIS THERAPEUTICS, INC.
Reel/Frame 041116/0681 →
Security Interest May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Security Interest Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
Release of Security Interest Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
Release of Security Interest Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
Security Interest Nov 30, 2022
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061929/0750 →
Assignment of Assignor's Interest Nov 20, 2023
From: AERIS THERAPEUTICS, LLC
To: PULMONX
Reel/Frame 065631/0026 →
Merger Nov 20, 2023
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 065631/0059 →
Security Interest Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
Security Interest Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
Release of Security Interest Mar 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 073980/0673 →